M
ISSUER//CIK 0001340752
Molecular Insight Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
MA
Recent Filings
- 8-K501.5 KBMolecular Insight Pharmaceuticals, Inc.May 11, 5:29 PM ET·0001193125-11-136095
- 8-K776.7 KBMolecular Insight Pharmaceuticals, Inc.May 4, 5:06 PM ET·0001193125-11-126307
- SC 13G/A9.5 KBMolecular Insight Pharmaceuticals, Inc.Apr 20, 10:59 AM ET·0001442757-11-000012
- 8-K317.7 KBMolecular Insight Pharmaceuticals, Inc.Apr 20, 6:06 AM ET·0001193125-11-102933
- SC 13G/A12.5 KBMolecular Insight Pharmaceuticals, Inc.Mar 28, 3:55 PM ET·0001442757-11-000005
- 8-K452.3 KBMolecular Insight Pharmaceuticals, Inc.Mar 16, 4:26 PM ET·0001193125-11-068711
- SC 13D/A107.3 KBMolecular Insight Pharmaceuticals, Inc.Mar 10, 5:22 PM ET·0001193125-11-062488
- SC 13D/A59.7 KBMolecular Insight Pharmaceuticals, Inc.Mar 9, 5:28 PM ET·0000905148-11-000608
- SC 13D/A27.5 KBMolecular Insight Pharmaceuticals, Inc.Mar 9, 3:23 PM ET·0001193125-11-060765
- SC 13D/A26.9 KBMolecular Insight Pharmaceuticals, Inc.Mar 9, 2:35 PM ET·0000950123-11-023580
Insiders
10- Abdalian Charles H JrVP of Finance and CFO
- Attarian Mark AInterim EVP & CFO
- Babich John WDirector, President, CEO and CSO
- Barlow David SDirector, 10% Owner
- Barrett John ASr. V.P. of Preclinical Dev
- Borys NicholasChief Medical Officer
- BRODY KENNETH DReference Footnote 1
- BROSENS FRANKReference footnote 1
- DONDERO JAMES DSee Footnote 1
- FEINBERG STEPHEN10% Owner
Tickers
No tickers on record
Addresses
business
160 SECOND STREET
CAMBRIDGE, MA, 02142
mailing
160 SECOND STREET
CAMBRIDGE, MA, 02142